Results 1 to 10 of about 332,362 (293)

The expression of tyrosine kinase and threonine promotes the progression of lung adenocarcinoma and is linked to a negative prognosis. [PDF]

Medicine (Baltimore)
Zhu X, Li S, Ye L, Ye L.
europepmc   +1 more source

Proteomic Snapshots of Structural Cross-Linking Rearrangements in Ca^2<b>+</b>/Calmodulin-Dependent Kinase-1-Delta Associated with Its Regulation by ATP, Ca^2<b>+</b>/Calmodulin, and Reduction Potential. [PDF]

J Proteome Res
Mbabala L, Tshililo NO, Vlok M, Vendrell I, Fischer R, Tabb DL, Trieber CA, Adra TRC, Overduin M, Butterworth S, Kenyon CP.   +10 more
europepmc   +1 more source

The dual-specificity phosphatase JSP1 regulates neutrophil adhesion via integrin-SRC signaling in vascular inflammation. [PDF]

J Biol Chem
Li L, Tonks NK.
europepmc   +1 more source

Kinase signaling in liver disease via clinical-trial-on-a-PamChip: A distinctive methodology for drug mechanisms and personalized medicine. [PDF]

J Biol Chem
Kipp ZA, Bates EA, Martinez GJ, Lee WH, Pauss SN, Hinds TD.   +5 more
europepmc   +1 more source

Pharmacophore-driven kinase profiling applied to the PKIS2 chemogenomic dataset. [PDF]

Sci Rep
Bureau R, Lamotte JL, Cuissart B, Lepailleur A.   +3 more
europepmc   +1 more source

Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS. [PDF]

Chest, 2014
Aschner Y, Zemans RL, Yamashita CM, Downey GP.   +3 more
europepmc   +1 more source

Curation of the Fasciola hepatica kinome as a resource for drug target discovery. [PDF]

BMC Genomics
Ajmera S, Puckelwaldt O, Stroehlein AJ, Haeberlein S.   +3 more
europepmc   +1 more source

Post-translational Modifications in Proteins: Prediction Methods, Biological Functions, and Diseases. [PDF]

MedComm (2020)
Zhang S, Li J, Chen M, Huang H.
europepmc   +1 more source

Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials. [PDF]

Front Pharmacol
Wali AF, Talath S, Babiker R, El-Tanani M, Rangraze IR, Ibraheem W, Al Aldhaheri Y, Satyam SM, El-Tanani Y.   +8 more
europepmc   +1 more source

A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance. [PDF]

Nat Commun
Karunaraj P, Scheele R, Wells ML, Rathod R, Gokulu IS, Abrahamson SR, Taylor L, Chowdhury L, Kazmi A, Song W, Hornbeck PV, Li J, Glasgow A, Vasan N.   +13 more
europepmc   +1 more source